FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2080975571> ?p ?o ?g. }

• W2080975571 endingPage "e56374" @default.
• W2080975571 startingPage "e56374" @default.
• W2080975571 abstract "Background Dogs are the main reservoir hosts of Leishmania infantum, the agent of human zoonotic visceral leishmaniosis. This study investigated the efficacy of a polymer matrix collar containing a combination of 10% imidacloprid and 4.5% flumethrin as a novel prophylactic measure to prevent L. infantum infections in young dogs from a hyper-endemic area of southern Italy, with a view towards enhancing current control strategies against both human and canine leishmaniosis. Methodology/Principal Findings The study was carried out on 124 young dogs, of which 63 were collared (Group A) while 61 were left untreated (Group B), from March-April 2011 until March 2012. Blood and skin samples were collected at baseline (April 2011) and at the first, second, third and fourth follow-up time points (July, September 2011 and November 2011, and March 2012, respectively). Bone marrow and conjunctiva were sampled at baseline and at the fourth follow-up. Serological, cytological and molecular tests were performed to detect the presence of L. infantum in the different tissues collected. At the end of the trial, no dog from Group A proved positive for L. infantum at any follow-up, whereas 22 dogs from Group B were infected (incidence density rate = 45.1%); therefore, the combination of 10% imidacloprid and 4.5% flumethrin was 100% efficacious for the prevention of L. infantum infection in young dogs prior to their first exposure to the parasite in a hyper-endemic area for CanL. Conclusions The use of collars containing 10% imidacloprid and 4.5% flumethrin conferred long-term protection against infection by L. infantum to dogs located in a hyper-endemic area, thus representing a reliable and sustainable strategy to decrease the frequency and spread of this disease among the canine population which will ultimately result in the reduction of associated risks to human health." @default.
• W2080975571 created "2016-06-24" @default.
• W2080975571 creator A5000235531 @default.
• W2080975571 creator A5008100634 @default.
• W2080975571 creator A5009790363 @default.
• W2080975571 creator A5031287928 @default.
• W2080975571 creator A5045152551 @default.
• W2080975571 creator A5047010731 @default.
• W2080975571 creator A5049120075 @default.
• W2080975571 creator A5058894113 @default.
• W2080975571 creator A5067464239 @default.
• W2080975571 creator A5075077614 @default.
• W2080975571 creator A5083244058 @default.
• W2080975571 creator A5091839965 @default.
• W2080975571 date "2013-02-25" @default.
• W2080975571 modified "2023-09-27" @default.
• W2080975571 title "Prevention of Canine Leishmaniosis in a Hyper-Endemic Area Using a Combination of 10% Imidacloprid/4.5% Flumethrin" @default.
• W2080975571 cites W1964628266 @default.
• W2080975571 cites W2000719201 @default.
• W2080975571 cites W2004074265 @default.
• W2080975571 cites W2011530743 @default.
• W2080975571 cites W2015360220 @default.
• W2080975571 cites W2020785604 @default.
• W2080975571 cites W2025899290 @default.
• W2080975571 cites W2026535663 @default.
• W2080975571 cites W2026618016 @default.
• W2080975571 cites W2046144222 @default.
• W2080975571 cites W2053150635 @default.
• W2080975571 cites W2053944579 @default.
• W2080975571 cites W2063282684 @default.
• W2080975571 cites W2071438260 @default.
• W2080975571 cites W2074748300 @default.
• W2080975571 cites W2090930804 @default.
• W2080975571 cites W2096222436 @default.
• W2080975571 cites W2098031413 @default.
• W2080975571 cites W2098659222 @default.
• W2080975571 cites W2100292009 @default.
• W2080975571 cites W2105169429 @default.
• W2080975571 cites W2131736110 @default.
• W2080975571 cites W2131902485 @default.
• W2080975571 cites W2135592181 @default.
• W2080975571 cites W2139254034 @default.
• W2080975571 cites W2141677295 @default.
• W2080975571 cites W2144802819 @default.
• W2080975571 cites W2149000113 @default.
• W2080975571 cites W2167970992 @default.
• W2080975571 cites W2169460918 @default.
• W2080975571 cites W4230530740 @default.
• W2080975571 doi "https://doi.org/10.1371/journal.pone.0056374" @default.
• W2080975571 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3581506" @default.
• W2080975571 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/23451043" @default.
• W2080975571 hasPublicationYear "2013" @default.
• W2080975571 type Work @default.
• W2080975571 sameAs 2080975571 @default.
• W2080975571 citedByCount "52" @default.
• W2080975571 countsByYear W20809755712013 @default.
• W2080975571 countsByYear W20809755712014 @default.
• W2080975571 countsByYear W20809755712015 @default.
• W2080975571 countsByYear W20809755712016 @default.
• W2080975571 countsByYear W20809755712017 @default.
• W2080975571 countsByYear W20809755712018 @default.
• W2080975571 countsByYear W20809755712019 @default.
• W2080975571 countsByYear W20809755712020 @default.
• W2080975571 countsByYear W20809755712021 @default.
• W2080975571 countsByYear W20809755712022 @default.
• W2080975571 crossrefType "journal-article" @default.
• W2080975571 hasAuthorship W2080975571A5000235531 @default.
• W2080975571 hasAuthorship W2080975571A5008100634 @default.
• W2080975571 hasAuthorship W2080975571A5009790363 @default.
• W2080975571 hasAuthorship W2080975571A5031287928 @default.
• W2080975571 hasAuthorship W2080975571A5045152551 @default.
• W2080975571 hasAuthorship W2080975571A5047010731 @default.
• W2080975571 hasAuthorship W2080975571A5049120075 @default.
• W2080975571 hasAuthorship W2080975571A5058894113 @default.
• W2080975571 hasAuthorship W2080975571A5067464239 @default.
• W2080975571 hasAuthorship W2080975571A5075077614 @default.
• W2080975571 hasAuthorship W2080975571A5083244058 @default.
• W2080975571 hasAuthorship W2080975571A5091839965 @default.
• W2080975571 hasBestOaLocation W20809755711 @default.
• W2080975571 hasConcept C159654299 @default.
• W2080975571 hasConcept C161176658 @default.
• W2080975571 hasConcept C203014093 @default.
• W2080975571 hasConcept C2776555147 @default.
• W2080975571 hasConcept C2776784398 @default.
• W2080975571 hasConcept C2778689377 @default.
• W2080975571 hasConcept C2781257258 @default.
• W2080975571 hasConcept C42972112 @default.
• W2080975571 hasConcept C45189115 @default.
• W2080975571 hasConcept C6557445 @default.
• W2080975571 hasConcept C71924100 @default.
• W2080975571 hasConcept C86803240 @default.
• W2080975571 hasConceptScore W2080975571C159654299 @default.
• W2080975571 hasConceptScore W2080975571C161176658 @default.
• W2080975571 hasConceptScore W2080975571C203014093 @default.
• W2080975571 hasConceptScore W2080975571C2776555147 @default.
• W2080975571 hasConceptScore W2080975571C2776784398 @default.
• W2080975571 hasConceptScore W2080975571C2778689377 @default.
• W2080975571 hasConceptScore W2080975571C2781257258 @default.

• next